Credit Suisse reiterated coverage on Clover Health Investments with a new price target

11/15/21 8:06:08 AM ET

Medical Specialities

Health Care

Credit Suisse reiterated coverage of Clover Health Investments with a rating of Neutral and set a new price target of $9.00 from $8.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CLOV

Date	Price Target	Rating	Analyst
12/17/2024	$6.00	Buy	Craig Hallum
10/7/2024	$4.00	Neutral	UBS
2/25/2022	$3.00 → $2.50	Market Perform	SVB Leerink
2/2/2022	$7.00 → $3.00	Underperform → Market Perform	Cowen & Co.
2/2/2022	$6.00	Buy	Canaccord Genuity
1/19/2022	$3.00	Market Perform	SVB Leerink
1/10/2022	$9.00 → $3.50	Neutral	Citigroup
1/7/2022	$9.00 → $3.50	Neutral → Underperform	Credit Suisse